Telesis Bio
TBIO0.00110.00% ( 0.0000 )
Telesis Bio (TBIO)
Telesis Bio, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, pr...
- Open
- 0.0011
- High
- 0.0011
- Low
- 0.0011
- Prev. Close
- 0.0011
- Volume
- 47
- Turnover
- 0.06
- Avg Price
- 0.0012
- Bid/Ask Ratio
- --
- Amplitude
- 0.00%
- 52wk High
- 0.1500
- Volume Ratio
- 0.11
- Turnover Ratio
- 0.00%
Telesis Bio Analyst Rating
View MoreForecast & Rating
Aug 22, 2024Price forecast
$72.006545349.09%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Unusual Whales · Apr 29 at 12:01 AM
Biotalys Reports Full-Year 2025 Financial Results and Business Highlights
- Pharmaceutical Technology · Apr 16 at 04:39 AM
Terremoto wins $108m in Series C to drive cancer and rare disease programmes
- Tip Ranks · Mar 17 at 09:52 AM
Telesia Extends Timetable for 2025 Accounts and Updates 2026 Financial Calendar
- Tip Ranks · Mar 10 at 06:28 AM
Satellos Bioscience Unveils Positive Interim SAT-3247 Data in Duchenne Muscular Dystrophy at MDA 2026
- Tip Ranks · Feb 18 at 01:27 PM
Satellos to Host February 24 Virtual KOL Event Showcasing SAT-3247 in Duchenne Muscular Dystrophy
- Baystreet · Feb 12 at 09:22 AM
Stocks in Play: Satellos Bioscience Inc.
